Skip to content
Screener

Akebia Therapeutics AKBA Q2 2026 earnings

Reported August 5, 2026 · After market close

Revenue$49.1MBeat by $276.0K
EPS-$0.02Beat by $0.02
Revenue estimate$48.9M
EPS estimate-$0.04

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$46.9M
EPS estimate-$0.03

FAQ

When did Akebia Therapeutics report Q2 2026 earnings?
Akebia Therapeutics (AKBA) reported Q2 2026 earnings on August 5, 2026 after market close.
What were Akebia Therapeutics's Q2 2026 revenue and EPS?
Akebia Therapeutics reported revenue of $49.1M and eps of $-0.02 for Q2 2026.
Did Akebia Therapeutics beat estimates in Q2 2026?
Revenue beat the consensus estimate of $48.9M by $276.0K. EPS beat the consensus estimate of $-0.04 by $0.02.
How did Akebia Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 21.4% from $62.5M a year earlier.
Where can I find Akebia Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001517022-26-000050) and the 10-Q periodic report (0001517022-26-000051) directly on SEC EDGAR. The filing index links above go to sec.gov.